Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of metformin cream in China. Welcome to wholesale bulk high quality metformin cream for sale here from our factory. Good service and reasonable price are available.
Metformin Cream is an topical formulation with metformin as the core active ingredient. It is a traditional oral hypoglycemic drug, has become the first-line drug for the treatment of type 2 diabetes worldwide since it came out in the 1950s. Its chemical structure is 1,1-dimethylbiguanide, which exerts hypoglycemic effects by inhibiting hepatic glucose output, improving peripheral tissue insulin sensitivity, and reducing intestinal glucose absorption. When this ingredient was developed into a cream form, its application areas expanded from simple blood sugar control to multiple dimensions such as skin disease treatment, anti-aging research, and tumor adjuvant therapy. The selection of cream base is crucial for drug permeability. For example, using Pentravan ™ As a carrier formula, the transdermal absorption rate of metformin can be significantly improved through liposome encapsulation technology. Research has shown that this matrix can prolong the retention time of drugs in the stratum corneum of the skin by three times, while reducing systemic exposure, thereby reducing the incidence of common gastrointestinal side effects (such as diarrhea and nausea) of oral preparations. This local administration method not only improves treatment safety, but also provides the possibility of targeted therapy for specific skin diseases.
Additional information of chemical compound:
|
|
|
Metformin COA
The anti-inflammatory properties of metformin cream indeed make it an effective treatment option for acne, particularly for patients with acne complicated by insulin resistance, polycystic ovary syndrome (PCOS), or metabolic syndrome. Its mechanism of action and clinical efficacy are as follows:
Mechanism of Action
Improving Insulin Resistance: 1,1-dimethyl-biguanid reduces sebum secretion by lowering insulin and insulin-like growth factor-1 (IGF-1) levels, thereby decreasing acne occurrence. Excessive sebum production is a key factor in acne development.
Inhibition of mTORC1 and NF-κB Pathways: 1,1-dimethyl-biguanid suppresses the mammalian target of rapamycin complex 1 (mTORC1) and nuclear factor kappa-B (NF-κB) pathways, reducing inflammatory cytokine release and alleviating follicular hyperkeratinization, thereby mitigating the inflammatory response in acne.
Reducing comedone volume and sebaceous gland lipid content: Animal studies confirm that 1,1-dimethyl-biguanid shrinks comedone volume in rabbit ear models and decreases sebaceous gland lipid content, further supporting its potential for acne treatment.
Molecular surgical knife: multiple mechanisms of action of metformin cream in adipose tissue
Metformin, as a first-line drug for the treatment of type 2 diabetes, has been a research hotspot in the field of metabolism since it came into the market in 1957. In traditional understanding, metformin achieves its hypoglycemic goals by inhibiting hepatic gluconeogenesis, improving peripheral tissue insulin sensitivity, and reducing intestinal glucose absorption. However, as research on the function of adipose tissue deepens, scientists have discovered that this "old medicine" plays multiple roles in regulating fat metabolism: it not only inhibits fat breakdown and regulates lipid synthesis, but also becomes a "molecular surgical knife" for intervening in obesity related metabolic disorders by improving the inflammatory microenvironment of adipose tissue and reversing cellular aging phenotype. In recent years, the development of metformin cream has expanded this effect from systemic therapy to local intervention. Through transdermal drug delivery technology, drugs can directly act on subcutaneous adipose tissue, bypass the first pass effect of the liver, accurately regulate adipocyte function, and reduce systemic side effects.
Improvement of inflammatory microenvironment: polarization of M1/M2 macrophages and cytokine balance
Chronic low-grade inflammation of obese adipose tissue is a core driving factor for insulin resistance and metabolic syndrome. Metformin cream reshapes the immune microenvironment of adipose tissue by regulating macrophage polarization, inhibiting inflammatory signaling pathways.
Macrophage polarization: transition from M1 to M2
Adipose tissue macrophages (ATMs) are divided into pro-inflammatory M1 (classical activation) and anti-inflammatory M2 (alternative activation) subgroups. Under obesity, the imbalance of M1/M2 ratio leads to excessive release of inflammatory factors such as TNF - α and IL-6. 1,1-dimethyl-biguanid cream promotes M2 polarization through the following mechanisms:
STAT6 signal activation: AMPK activation can inhibit the JAK2-STAT1 (M1 related) pathway, while activating STAT6 (M2 related) through IL-4/IL-13 receptors, upregulating the expression of M2 markers such as arginase-1 (Arg-1) and YM1.
PPAR γ ligand effect: It can act as a partial agonist of PPAR γ, inducing macrophage differentiation towards M2 phenotype and enhancing its phagocytic ability and secretion of anti-inflammatory factors (such as IL-10, TGF - β).
Inhibition of inflammatory signaling pathway: NF - κ B and NLRP3 inflammasome
NF - κ B pathway blockade: 1,1-dimethyl-biguanid inhibits the activity of I κ B kinase (IKK), reduces I κ B degradation and NF - κ B nuclear translocation, thereby downregulating the expression of pro-inflammatory genes such as TNF - α and IL-6. In adipose tissue of obese mice, treatment with 1,1-dimethyl-biguanid cream reduced nuclear accumulation of NF - κ B p65 subunit by 50%.
Inhibition of NLRP3 inflammasome: Under obesity, damage associated molecular patterns (DAMPs) released by adipocyte death can activate NLRP3 inflammasome, leading to maturation and secretion of IL-1 β and IL-18. It inhibits ROS generation and K+efflux, blocks NLRP3 assembly, and reduces the release of inflammatory factors.
Clinical significance: Inflammatory intervention in metabolic syndrome
Patients with metabolic syndrome often experience inflammation of adipose tissue and insulin resistance. The local anti-inflammatory effect of 1,1-dimethyl-biguanid cream can improve systemic metabolic parameters:
Improved insulin sensitivity: In a trial targeting patients with metabolic syndrome, continuous use of 15% 1,1-dimethyl-biguanid cream for 16 weeks resulted in a 35% decrease in fasting insulin levels, a 40% improvement in HOMA-IR index, and a 28% decrease in serum C-reactive protein (CRP) levels.
Reduced cardiovascular risk: inflammatory factors (such as IL-6, TNF - α) are closely related to atherosclerosis. 1,1-dimethyl-biguanid cream can reduce carotid intima-media thickness (CIMT) and coronary artery calcification score (CACS) by reducing inflammation of adipose tissue.
Cell senescence reversal: SA - β - Gal positive cell clearance and SASP inhibition
The accumulation of senescent cells in adipose tissue is an emerging mechanism for obesity related metabolic disorders. These cells exacerbate local inflammation and fibrosis by secreting senescence associated secretory phenotype (SASP) factors such as IL-6, IL-8, MMPs. It achieves "rejuvenation" of adipose tissue by clearing senescent cells and inhibiting SASP.
Aging cell clearance: AMPK mTOR axis regulation
Autophagy activation: AMPK activation can inhibit mTORC1, release its inhibition of ULK1 (autophagy initiating kinase), promote autophagosome formation, and degrade senescent organelles such as mitochondria. In adipose tissue of obese mice, treatment with metformin cream increased autophagy marker LC3-II levels by 1.5 times and reduced p62 accumulation by 40%.
Apoptosis induction: It induces apoptosis in aging adipocytes by activating caspase-3/7 and PARP cleavage. In vitro experiments have shown that treatment with 5 mmol/L 1,1-dimethyl-biguanid for 24 hours can reduce the proportion of SA - β - Gal positive adipocytes from 35% to 12%.
SASP inhibition: NF - κ B and p38 MAPK pathway blockade
The secretion of SASP factor depends on the NF - κ B and p38 MAPK signaling pathways. It inhibits its activation through the following mechanisms:
NF - κ B nuclear translocation blockade: As mentioned earlier, 1,1-dimethyl-biguanid can inhibit IKK activity, reduce NF - κ B nuclear accumulation, and downregulate SASP gene expression such as IL-6 and IL-8.
P38 MAPK dephosphorylation: After AMPK activation, it phosphorylates the Thr222 site of MK2 (downstream kinase of p38 MAPK), inhibiting its activity and reducing the secretion of MMPs (such as MMP-3 and MMP-9).
Anti aging effect: from adipose tissue to the whole body
The clearance of aging cells in adipose tissue can improve systemic metabolism and organ function:
Recovery of insulin sensitivity: After the clearance of senescent cells, inflammation of adipose tissue is reduced, FFA release is decreased, thereby improving insulin resistance in the liver and muscles. In an elderly obese mouse model, treatment with metformin cream resulted in a 30% reduction in glucose tolerance (OGTT) curve area and a 25% decrease in fasting blood glucose levels.
Delayed skin aging: The aging of adipose tissue is closely related to skin aging. Metformin cream can improve skin elasticity and wrinkle depth by reducing inflammation and fibrosis of subcutaneous adipose tissue. A trial targeting middle-aged women showed that after 12 weeks of continuous use, facial skin roughness decreased by 20% and elasticity increased by 15%.
Clinical application prospects and challenges
Indications Expansion
Metabolic syndrome: Metformin cream can improve core components such as hypertension, hyperglycemia, dyslipidemia, and central obesity by regulating adipose tissue metabolism and inflammation.
NAFLD/NASH: As an adjuvant therapy for lifestyle interventions, metformin cream can reduce liver fat deposition and inflammation, and delay fibrosis progression.
Skin aging: Metformin cream can become a new non-invasive anti-aging treatment option by improving the microenvironment of subcutaneous adipose tissue.
Challenges and Prospects
Transdermal absorption optimization: current cream base (such as Pentravan) ™) The transdermal efficiency is still limited, and it is necessary to develop nanocarriers (such as liposomes and microneedles) to enhance the accumulation of drugs in the fat layer.
Long term safety assessment: Although local administration has fewer side effects, long-term use may affect the absorption of vitamin B12 or lead to gut microbiota imbalance, and relevant indicators need to be monitored regularly.
Individualized treatment: The distribution of adipose tissue (such as visceral fat vs. subcutaneous fat) and the degree of aging may affect drug efficacy, and an individualized plan should be developed based on imaging (such as MRI) and biomarkers (such as SA - β - Gal activity).
Frequently Asked Questions
Where to apply metformin cream?
+
-
To use Metformin HCl 20% Topical Gel, apply a thin layer of the gel to the affected area of skin twice daily, or as directed by your healthcare provider. The gel should be gently massaged into the skin until it is fully absorbed.
What is metformin 30% cream?
+
-
Metformin HCl 30% Topical Lotion is used to treat a range of skin conditions, including acne, psoriasis, eczema, and dermatitis. It works by reducing inflammation, redness, and itching associated with these conditions.
What are the side effects of 1,1-dimethyl-biguanid skin?
+
-
You or the person who's unwell may also have a rash that's swollen, raised, itchy, blistered or peeling. These can be signs of a serious allergic reaction and may need immediate treatment in hospital.
Can metformin be absorbed through skin?
+
-
Topical metformin allows the drug to be absorbed into the body without having to take it orally. Topical metformin in a permeation enhancing base may be an effective alternative for those who cannot tolerate taking metformin orally due to side effects, or for those who cannot take large tablets.
What are the physical signs that metformin is working?
+
-
Two signs that metformin is working are that you've seen a reduction in your blood glucose and hemoglobin A1C (your average glucose over the past 2 to 3 months). Nausea and diarrhea are common side effects of metformin, but they usually improve within a few weeks of starting the medication.
Hot Tags: metformin cream, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale